Comment on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604.
作者信息
Engel Samuel S, Golm Gregory T, Lauring Brett
机构信息
Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey.
出版信息
Diabetes. 2013 Oct;62(10):e18. doi: 10.2337/db13-0525.
Abstract
摘要
相似文献
1
Comment on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604.评论：巴特勒等人。在患有外分泌胰腺发育异常增加且有产生胰高血糖素的神经内分泌肿瘤潜在风险的人类中，肠促胰岛素疗法使外分泌和内分泌胰腺显著扩张。《糖尿病》2013年；62卷：2595 - 2604页。
Diabetes. 2013 Oct;62(10):e18. doi: 10.2337/db13-0525.
2
Comment on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604.评论：巴特勒等人。在患有外分泌胰腺发育异常增加及存在产生胰高血糖素的神经内分泌肿瘤可能性的人类中，肠促胰岛素疗法可使外分泌和内分泌胰腺显著扩张。《糖尿病》2013年；62卷：2595 - 2604页。
Diabetes. 2013 Oct;62(10):e16-7. doi: 10.2337/db13-0690.
3
Response to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604.对关于以下内容的评论的回应：巴特勒等人。在患有外分泌胰腺发育异常增加和产生胰高血糖素的神经内分泌肿瘤潜在风险的人类中，肠促胰岛素治疗使外分泌和内分泌胰腺显著扩张。《糖尿病》2013年；62卷：2595 - 2604页。
Diabetes. 2013 Oct;62(10):e19-22. doi: 10.2337/db13-0996.
4
Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.外分泌和内分泌胰腺在具有外分泌胰腺发育不良增加的人类中随着肠促胰岛素治疗而显著扩张，并且具有产生胰高血糖素的神经内分泌肿瘤的潜力。
Diabetes. 2013 Jul;62(7):2595-604. doi: 10.2337/db12-1686. Epub 2013 Mar 22.
5
Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies.肠促胰岛素疗法对胰腺影响研究的重新分析：方法学缺陷
Diabetes Obes Metab. 2014 Jul;16(7):661-6. doi: 10.1111/dom.12257. Epub 2014 Jan 29.
6
Incretin therapy and islet pathology: a time for caution.肠促胰岛素治疗与胰岛病理学：需谨慎对待的时候了。
Diabetes. 2013 Jul;62(7):2178-80. doi: 10.2337/db13-0520. Epub 2013 Apr 17.
7
Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapies.接受基于肠促胰岛素疗法的患者胰腺内分泌和外分泌组织的组织学变化。
Diabetes Obes Metab. 2016 Dec;18(12):1253-1262. doi: 10.1111/dom.12766. Epub 2016 Sep 26.
8
Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice.肠促胰岛素疗法不会增加年轻雄性小鼠的β细胞量或改变胰腺组织学。
Endocrinology. 2017 Jun 1;158(6):1701-1714. doi: 10.1210/en.2017-00027.
9
Immunohistochemical assessment of glucagon-like peptide 1 receptor (GLP-1R) expression in the pancreas of patients with type 2 diabetes.2型糖尿病患者胰腺中胰高血糖素样肽1受体（GLP-1R）表达的免疫组织化学评估
Diabetes Obes Metab. 2017 May;19(5):705-712. doi: 10.1111/dom.12879. Epub 2017 Mar 10.
10
Lipotoxicity impairs incretin signalling.脂毒性损害肠促胰岛素信号转导。
Diabetologia. 2013 Feb;56(2):231-3. doi: 10.1007/s00125-012-2788-6. Epub 2012 Nov 28.
引用本文的文献
1
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions.糖尿病合并神经内分泌肿瘤患者的肠促胰岛素和钠-葡萄糖协同转运蛋白2抑制剂：最新进展与未来方向
Rev Endocr Metab Disord. 2025 Apr 2. doi: 10.1007/s11154-025-09958-5.
2
The Relationship Between Dipeptidyl Peptidase-4 Inhibitor Usage and Asymptomatic Amylase Lipase Increment in Type 2 Diabetes Mellitus Patients.2型糖尿病患者使用二肽基肽酶-4抑制剂与无症状淀粉酶脂肪酶升高之间的关系
Turk J Pharm Sci. 2020 Feb;17(1):68-73. doi: 10.4274/tjps.galenos.2018.83788. Epub 2020 Feb 19.
3
Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice.肠促胰岛素疗法不会增加年轻雄性小鼠的β细胞量或改变胰腺组织学。
Endocrinology. 2017 Jun 1;158(6):1701-1714. doi: 10.1210/en.2017-00027.
4
Glucagon-Like Peptide-1 Receptor Expression in Normal and Neoplastic Human Pancreatic Tissues.胰高血糖素样肽-1受体在正常及肿瘤性人类胰腺组织中的表达
Pancreas. 2016 Apr;45(4):613-9. doi: 10.1097/MPA.0000000000000521.
5
Studying pancreatic risks caused by incretin-based therapies: is it a game? It's not a game!研究基于肠促胰岛素的疗法所引发的胰腺风险：这是一场游戏吗？这可不是一场游戏！
J Diabetes Sci Technol. 2014 Jul;8(4):895-7. doi: 10.1177/1932296814532874. Epub 2014 May 12.
6
Action and therapeutic potential of oxyntomodulin.胃泌酸调节素的作用及治疗潜力。
Mol Metab. 2013 Dec 14;3(3):241-51. doi: 10.1016/j.molmet.2013.12.001. eCollection 2014 Jun.
7
Response to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:2595-2604.对关于以下内容的评论的回应：巴特勒等人。在患有外分泌胰腺发育异常增加和产生胰高血糖素的神经内分泌肿瘤潜在风险的人类中，肠促胰岛素治疗使外分泌和内分泌胰腺显著扩张。《糖尿病》2013年；62卷：2595 - 2604页。
Diabetes. 2013 Oct;62(10):e19-22. doi: 10.2337/db13-0996.
本文引用的文献
1
Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors.外分泌和内分泌胰腺在具有外分泌胰腺发育不良增加的人类中随着肠促胰岛素治疗而显著扩张，并且具有产生胰高血糖素的神经内分泌肿瘤的潜力。
Diabetes. 2013 Jul;62(7):2595-604. doi: 10.2337/db12-1686. Epub 2013 Mar 22.
2
Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes.患有1型糖尿病相关自身抗体且有患病风险个体的胰腺器官重量。
JAMA. 2012 Dec 12;308(22):2337-9. doi: 10.1001/jama.2012.15008.
3
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes.考虑到性别、肥胖和2型糖尿病的存在，对从出生到100岁的人类胰腺体积进行研究。
Clin Anat. 2007 Nov;20(8):933-42. doi: 10.1002/ca.20543.
4
Estimation of pancreas weight from donor variables.根据供体变量估算胰腺重量。
Cell Transplant. 2006;15(2):181-5. doi: 10.3727/000000006783982133.
5
Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.胰腺上皮内瘤变的临床病理相关性：82例伴有胰腺导管腺癌与152例不伴有胰腺导管腺癌病例的对比分析
Mod Pathol. 2003 Oct;16(10):996-1006. doi: 10.1097/01.MP.0000087422.24733.62.
Zotero 插件